Prudential Financial
TLSI icon

Prudential Financial’s TriSalus Life Sciences TLSI Stock Holding History

Prudential Financial’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$55.2K – 2515
2025
Q1 		$55.2K Buy
+10,000
New +$53.2K ﹤0.01% 2188

Other funds holding TLSI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prudential Financial's TLSI Position: Q2 2025 in Review

Prudential Financial sold out of TriSalus Life Sciences (TLSI) in Q2 2025, closing a stake of 10,000 shares — an estimated $55.2K sold.

Prudential Financial first reported a position in TLSI in Q1 2025 and held it in 1 quarter. The position peaked at $55.2K in Q1 2025. 48 funds tracked by Wall St. Rank hold TLSI as of Q2 2025.

  • Prudential Financial reported no remaining TriSalus Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 10,000 TriSalus Life Sciences shares in Q2 2025, an estimated $55.2K.
  • Prudential Financial first reported a position in TriSalus Life Sciences in Q1 2025 and held it in 1 quarter.
  • Prudential Financial's TriSalus Life Sciences position peaked at $55.2K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.